Preferred Label : indacaterol;
MeSH note : a beta2 adrenoceptor agonist; indacaterol is the (R)-isomer; structure in first source;
CISMeF synonym : QAB-149; arcapta neohaler; onbrez;
MeSH synonym : 5-(2-(5,6-diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one;
Is substance : O;
UNII : 8OR09251MQ;
InChIKey : QZZUEBNBZAPZLX-QFIPXVFZSA-N;
Origin ID : C510790;
UMLS CUI : C1722260;
ATC code(s)
CISMeF manual mappings
MeSH term(s) associated for indexing
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3481441/fr/ultibro-breezhaler-indacaterol/bromure-de-glycopyrronium-bronchopneumopathie-chronique-obstructive-bpco
2024
false
false
false
France
indacaterol
insurance, health, reimbursement
treatment outcome
drug combinations
indacaterol-glycopyrronium combination
adult
administration, inhalation
evaluation of the transparency committee
Glycopyrronium
pulmonary disease, chronic obstructive
---
https://www.has-sante.fr/jcms/p_3227239/fr/atectura-breezhaler
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
indacaterol and mometasone
drug combinations
administration, inhalation
indacaterol
adrenergic beta-2 receptor agonists
Mometasone Furoate
anti-inflammatory agents
asthma
adult
adolescent
evaluation of the transparency committee
---
https://www.has-sante.fr/jcms/p_3242947/fr/enerzair-breezhaler
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug combinations
administration, inhalation
indacaterol, glycopyrronium bromide and mometasone
Mometasone Furoate
indacaterol
adrenergic beta-2 receptor agonists
muscarinic antagonists
anti-inflammatory agents
guidelines for drug use
adult
asthma
evaluation of the transparency committee
glycopyrrolate
indans
quinolones
---
https://www.ema.europa.eu/en/medicines/human/EPAR/enerzair-breezhaler
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
indacaterol
indacaterol
indacaterol, glycopyrronium bromide and mometasone
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
muscarinic antagonists
muscarinic antagonists
Mometasone Furoate
Mometasone Furoate
administration, inhalation
asthma
adult
anti-inflammatory agents
anti-inflammatory agents
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
glycopyrrolate
glycopyrrolate
indans
quinolones
indans
quinolones
---
https://www.ema.europa.eu/en/medicines/human/EPAR/zimbus-breezhaler
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
administration, inhalation
drug combinations
glycopyrrolate
glycopyrrolate
muscarinic antagonists
muscarinic antagonists
indacaterol
indacaterol
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
Mometasone Furoate
Mometasone Furoate
anti-inflammatory agents
anti-inflammatory agents
asthma
adult
aged
drug interactions
pregnancy
breast feeding
indacaterol, glycopyrronium bromide and mometasone
drug evaluation, preclinical
indans
quinolones
indans
quinolones
---
https://www.ema.europa.eu/en/medicines/human/EPAR/atectura-breezhaler
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
indacaterol
indacaterol
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
indacaterol and mometasone
mometasone
mometasone
anti-inflammatory agents
anti-inflammatory agents
bronchodilator agents
bronchodilator agents
adult
adolescent
asthma
administration, inhalation
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Mometasone Furoate
Mometasone Furoate
indans
quinolones
indans
quinolones
---
https://www.ema.europa.eu/en/medicines/human/EPAR/bemrist-breezhaler
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
administration, inhalation
indacaterol
indacaterol
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
mometasone
mometasone
anti-inflammatory agents
anti-inflammatory agents
indacaterol and mometasone
adult
adolescent
asthma
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Mometasone Furoate
Mometasone Furoate
indans
quinolones
indans
quinolones
---
https://www.has-sante.fr/jcms/p_3215558/fr/enerzair-breezhaler
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
administration, inhalation
Mometasone Furoate
indacaterol
adrenergic beta-2 receptor agonists
muscarinic antagonists
anti-inflammatory agents
indacaterol, glycopyrronium bromide and mometasone
asthma
adult
bronchodilator agents
evaluation of the transparency committee
glycopyrrolate
indans
quinolones
---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/atectura-breezhaler-5427.html
2020
false
false
false
Canada
French
drug evaluation
indacaterol and mometasone
drug combinations
administration, inhalation
asthma
indacaterol
Mometasone Furoate
indans
quinolones
---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/enerzair-breezhaler-5428.html
2020
false
false
false
Canada
French
asthma
drug combinations
administration, inhalation
drug evaluation
Mometasone Furoate
indacaterol
indacaterol, glycopyrronium bromide and mometasone
glycopyrrolate
indans
quinolones
---
https://www.has-sante.fr/portail/jcms/c_2807276/fr/ultibro-breezhaler-indacaterol-glycopyrronium-bronchodilatateur-de-longue-duree-d-action
https://www.has-sante.fr/portail/jcms/c_2807276/fr/ultibro-breezhaler
2017
false
false
France
French
indacaterol and glycopyrronium bromide
evaluation of the transparency committee
Indacaterol Maleate
insurance, health, reimbursement
treatment outcome
bronchodilator agents
guidelines for drug use
indacaterol
glycopyrrolate
drug combinations
administration, inhalation
muscarinic antagonists
adrenergic beta-2 receptor agonists
pulmonary disease, chronic obstructive
adult
indans
quinolones
---
http://www.has-sante.fr/portail/jcms/c_2610170/fr/ultibro-breezhaler
2016
false
France
French
indacaterol and glycopyrronium bromide
evaluation of the transparency committee
Indacaterol Maleate
insurance, health, reimbursement
treatment outcome
bronchodilator agents
indacaterol
glycopyrrolate
drug combinations
administration, inhalation
muscarinic antagonists
adrenergic beta-2 receptor agonists
pulmonary disease, chronic obstructive
adult
indans
quinolones
---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1010
2015
false
false
false
false
Canada
French
drug combinations
administration, inhalation
indacaterol-glycopyrronium combination
indacaterol
critical appraisal or critical reading
glycopyrrolate
cholinergic antagonists
adrenergic beta-2 receptor agonists
pulmonary disease, chronic obstructive
bronchodilator agents
treatment outcome
multicenter studies as topic
COPD exacerbation
disease exacerbation
indacaterol and glycopyrronium bromide
quality of life
disease progression
indans
quinolones
glycopyrrolate
---
https://minerva-ebp.be/fr/article/1054
2015
false
false
false
minerva-ebm.be
Belgium
French
critical appraisal or critical reading
pulmonary disease, chronic obstructive
drug therapy, combination
treatment outcome
indacaterol
glycopyrrolate
muscarinic antagonists
bronchodilator agents
indacaterol-glycopyrronium combination
Tiotropium Bromide
indans
quinolones
glycopyrrolate
---
http://www.cochrane.org/fr/CD010139/lindacaterol-pour-le-traitement-de-personnes-atteintes-de-bpco-stable
2015
false
false
false
France
United Kingdom
French
review of literature
treatment outcome
pulmonary disease, chronic obstructive
indacaterol
adrenergic beta-2 receptor agonists
administration, inhalation
dose-response relationship, drug
drug administration schedule
french abstract
indans
quinolones
---
https://minerva-ebp.be/FR/Analysis/424
2015
false
true
false
Belgium
French
french abstract
scientific and technical information
adrenergic beta-agonists
treatment outcome
placebos
pulmonary disease, chronic obstructive
indacaterol
indans
quinolones
---
https://www.ema.europa.eu/medicines/human/EPAR/Ulunar-Breezhaler
2014
false
United Kingdom
French
English
indacaterol and glycopyrronium bromide
drug approval
europe
treatment outcome
drug combinations
glycopyrrolate
glycopyrrolate
indacaterol
indacaterol
administration, inhalation
adult
pulmonary disease, chronic obstructive
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
muscarinic antagonists
muscarinic antagonists
drug monitoring
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
summary of product characteristics
package leaflet
drug evaluation
syndication feed
clinical trials, phase iii as topic
drug evaluation, preclinical
indans
indans
quinolones
quinolones
---
http://www.has-sante.fr/portail/jcms/c_1744044/fr/ultibro-breezhaler-indacaterol-glycopyrronium-bronchodilatateur
2014
false
France
French
indacaterol and glycopyrronium bromide
evaluation of the transparency committee
Indacaterol Maleate
insurance, health, reimbursement
treatment outcome
bronchodilator agents
guidelines for drug use
indacaterol
glycopyrrolate
drug combinations
administration, inhalation
muscarinic antagonists
adrenergic beta-2 receptor agonists
pulmonary disease, chronic obstructive
adult
indans
quinolones
---
http://www.has-sante.fr/portail/jcms/c_1744044/fr/ultibro-breezhaler
2014
false
France
French
indacaterol and glycopyrronium bromide
evaluation of the transparency committee
Indacaterol Maleate
insurance, health, reimbursement
treatment outcome
bronchodilator agents
indacaterol
glycopyrrolate
drug combinations
administration, inhalation
muscarinic antagonists
adrenergic beta-2 receptor agonists
pulmonary disease, chronic obstructive
adult
indans
quinolones
---
https://www.ema.europa.eu/medicines/human/EPAR/Ultibro-Breezhaler
2013
false
United Kingdom
French
English
summary of product characteristics
package leaflet
indacaterol and glycopyrronium bromide
indacaterol
glycopyrrolate
indacaterol
drug combinations
administration, inhalation
glycopyrrolate
muscarinic antagonists
muscarinic antagonists
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
pulmonary disease, chronic obstructive
adult
drug evaluation
syndication feed
indans
indans
quinolones
quinolones
---
https://www.ema.europa.eu/medicines/human/EPAR/Xoterna-Breezhaler
2013
United Kingdom
French
English
indacaterol
glycopyrrolate
drug combinations
administration, inhalation
indacaterol
drug approval
europe
treatment outcome
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
adult
pulmonary disease, chronic obstructive
muscarinic antagonists
muscarinic antagonists
drug evaluation
syndication feed
indans
indans
quinolones
quinolones
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68637167
2012
France
summary of product characteristics
package leaflet
capsules
metered dose inhalers
maleic acid
maleates
indacaterol
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69189667
2012
France
summary of product characteristics
package leaflet
metered dose inhalers
capsules
indacaterol
maleic acid
maleates
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67062977
2012
France
summary of product characteristics
package leaflet
maleic acid
capsules
maleates
metered dose inhalers
indacaterol
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62036213
2012
France
summary of product characteristics
package leaflet
metered dose inhalers
indacaterol
capsules
---
https://www.ema.europa.eu/medicines/human/EPAR/Hirobriz-Breezhaler
2012
France
French
English
syndication feed
indans
quinolones
bronchodilator agents
bronchodilator agents
indacaterol
indacaterol
indans
quinolones
administration, inhalation
adult
aged
pulmonary disease, chronic obstructive
drug approval
drug labeling
treatment outcome
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug compounding
indacaterol
adrenergic beta-2 receptor agonists
drug evaluation
summary of product characteristics
package leaflet
---
https://www.ema.europa.eu/medicines/human/EPAR/Onbrez-Breezhaler
2012
United Kingdom
English
French
syndication feed
aged
pregnancy
breast feeding
drug interactions
quinolones
indacaterol
indans
indacaterol
indans
quinolones
drug approval
treatment outcome
drug labeling
administration, inhalation
adult
pulmonary disease, chronic obstructive
bronchodilator agents
drug evaluation, preclinical
bronchodilator agents
drug compounding
indacaterol
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
drug evaluation
summary of product characteristics
package leaflet
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00106
2012
false
false
false
Canada
Indacaterol 75microgram inhalation powder capsule (product)
indacaterol
indacaterol
drug information
indans
quinolones
---
https://www.ema.europa.eu/medicines/human/EPAR/Oslif-Breezhaler
2012
United Kingdom
English
French
syndication feed
indans
quinolones
indacaterol
indacaterol
quinolones
indans
bronchodilator agents
bronchodilator agents
pulmonary disease, chronic obstructive
administration, inhalation
adult
aged
drug approval
drug labeling
treatment outcome
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug compounding
indacaterol
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
drug evaluation
summary of product characteristics
package leaflet
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61742500
2012
France
package leaflet
summary of product characteristics
maleates
indacaterol
maleic acid
capsules
metered dose inhalers
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67084265
2012
France
summary of product characteristics
package leaflet
capsules
metered dose inhalers
indacaterol
---
https://minerva-ebp.be/fr/article/259
2011
false
minerva-ebm.be
Belgium
French
Dutch
indacaterol
indans
indans
quinolones
quinolones
indacaterol
pulmonary disease, chronic obstructive
treatment outcome
indacaterol
administration, inhalation
Delayed-Action preparations
adrenergic beta-2 receptor agonists
critical appraisal or critical reading
---
http://www.has-sante.fr/portail/jcms/c_1019687/onbrez-breezhaler-oslif-breezhaler-hirobriz-breezhaler
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/hirobriz_breezhaler_ct_8861.pdf
2010
France
French
English
evaluation of the transparency committee
indans
indacaterol
administration, inhalation
quinolones
indacaterol
bronchodilator agents
adrenergic beta-2 receptor agonists
insurance, health, reimbursement
pulmonary disease, chronic obstructive
treatment outcome
---
http://www.has-sante.fr/portail/jcms/c_1050933/onbrez-breezhaler-/-hirobriz-breezhaler-/-oslif-breezhaler-indacaterol-bronchodilatateur-de-longue-duree-daction
2010
France
French
evaluation of the transparency committee
guidelines for drug use
indacaterol
indacaterol
indans
indans
quinolones
quinolones
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
treatment outcome
pulmonary disease, chronic obstructive
indacaterol
insurance, health, reimbursement
administration, inhalation
---